Botulinum toxin for cerebral palsy; where are we now?

R E Morton; J Hankinson; J Nicholson

doi:10.1136/adc.2003.044560

Botulinum toxin for cerebral palsy; where are we now?

Arch Dis Child. 2004 Dec;89(12):1133-7. doi: 10.1136/adc.2003.044560.

Authors

R E Morton¹, J Hankinson, J Nicholson

Affiliation

¹ Ronnie MacKeith Child Development Centre, Derbyshire Children's' Hospital, Nottingham, UK. richard.morton@sdah-tr.trent.nhs.uk

Abstract

In this article, the evidence base for botulinum-A treatment acquired in recent years is outlined, and the practicalities involved in providing this service are described. Botulinum-A is relatively new, and possible improvements for the future are considered.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Botulinum Toxins, Type A / administration & dosage*
Cerebral Palsy / drug therapy*
Child
Child, Preschool
Forecasting
Humans
Injections, Intramuscular
Neuromuscular Agents / administration & dosage*
Randomized Controlled Trials as Topic

Substances

Neuromuscular Agents
Botulinum Toxins, Type A